Background
==========

NF-κB transcription factors are essential for innate and adaptive immunity, cell survival, cellular stress responses, development and maintenance of lymphoid organ structures, and other biological functions \[[@B1]-[@B3]\]. The vertebrate NF-κB family includes five structurally related members, the Rel proteins RelA (p65), RelB, cRel, and the NF-κB proteins p50 and p52. Among the Rel/NF-κB family, only RelA, RelB, and cRel contain C-terminal transcriptional activation domains enabling them to directly regulate transcription. The other two members, p50 and p52, are synthesized as p105 and p100 precursors, respectively. The Rel and NF-κB proteins can form different homo- and heterodimers (for example p50-RelA or p52-RelB) that bind to DNA target sites, so-called κB sites. In resting cells, Rel/NF-κB proteins associate with inhibitory κB molecules (IκBs) and are retained in the cytoplasm as inactive forms \[[@B4]\].

Two major NF-κB signaling pathways can be distinguished, the classical or canonical and the alternative or non-canonical pathway. In response to stimulation of transmembrane receptors like tumor necrosis factor receptor (TNFR)-1 or Toll-like receptor (TLR)-4, signaling cascades are initiated that lead to the liberation of Rel/NF-κB complexes from their IκB molecules. As a result, they translocate to the nucleus and regulate transcription of numerous target genes. This classical pathway involves phosphorylation of IκBα by the NEMO (NF-κB essential modulator)/IKKγ- and IKKβ-containing IκB kinase (IKK) complex followed by its ubiquitin-dependent proteasomal degradation. Regulation of gene transcription is predominantly mediated through p50-RelA and p50-cRel heterodimers and target genes are mainly involved in innate immunity, cell survival, and inflammation. A few inducers of NF-κB, like LTβR, are able to trigger an additional, so-called alternative or non-canonical pathway through the activation of NF-κB-inducing kinase (NIK) and IKKα. The alternative pathway governs gene regulation mainly through p52-RelB heterodimers that are generated from the inactive cytoplasmic p100-RelB complex via signal-dependent processing of the p100 inhibitor to p52. This pathway controls genes that are predominantly involved in adaptive immunity and lymphoid organ development \[[@B5]-[@B11]\]. Recent findings by Hoffmann and colleagues extend this scenario. They could show that not only RelB- but also RelA-containing complexes can be released from the p100 inhibitor after LTβR stimulation \[[@B12]-[@B14]\].

This report focuses on the transcriptional response downstream of the LTβR and its regulation by RelA and RelB. The role of LTβR signaling in development and organization of secondary lymphoid structures is well documented (reviewed in \[[@B8],[@B15]-[@B17]\]). We are interested in similarities and differences in RelA and RelB function in lymphoid organ development. However, a major problem is that RelA-deficient (*relA*^-/-^) mice are embryonic lethal due to tumor necrosis factor (TNF)-induced hepatocyte apoptosis \[[@B18]\]. Moreover, RelB-deficient (*relB*^-/-^) mice display impaired secondary lymphoid organ development and suffer from an autoinflammatory syndrome that also affects organization and function of lymphoid tissues \[[@B19],[@B20]\]. Thus, stromal compartments that display LTβR signaling and thereby have an organizational role in the development of lymphoid organs cannot be used for *in vivo*gene expression studies from the above animals. Therefore, we applied MEFs established from wild-type (wt), *relA*^-/-^, and *relB*^-/-^mice as an *in vitro*model system. Also, there is increasing evidence that LTβR functions beyond lymphoid organs, as it is involved in liver regeneration, hepatitis \[[@B21]\], and hepatic lipid metabolism \[[@B22]\]. We therefore hypothesized that LTβR signaling, via RelA and/or RelB, may participate in physiological processes other than lymphorganogenesis. MEFs with different genotypes (wt, *relA*^-/-^, and *relB*^-/-^) allowed us to dissect specific RelA and RelB activities in the regulation of gene transcription after LTβR stimulation. In wt MEFs, LTβR signals were predominantly transduced by RelA- and/or RelB-containing dimers. Upon LTβR signaling in *relA*^-/-^cells, gene regulatory events were mediated by RelB and *vice versa*in *relB*^-/-^cells, changes in gene expression were mediated by RelA. Using this system, we describe novel LTβR-responsive genes that were regulated solely by RelA or RelB or by both RelA and RelB.

Results and discussion
======================

LTβR stimulation of MEFs
------------------------

For LTβR stimulation, MEFs of each genotype were either left untreated or were treated with agonistic anti-LTβR monoclonal antibody (mAb) for 2.5 or 10 h. For each treatment group, cells from four experiments were pooled. Nuclear protein extracts were used in electrophoretic mobility shift assays (EMSAs) to verify proper LTβR signaling (Figure [1](#F1){ref-type="fig"}). In wt cells, LTβR signaling resulted in modest induction of κB-binding complexes at the early time point (2.5 h) but strong induction after 10 h of stimulation. Dissection of these complexes with supershifting antibodies revealed that the faster migrating complex contained RelB and the slower migrating complex contained RelA. As expected, in wt cells both RelA and RelB complexes were activated in response to LTβR signaling, whereas in *relA*^-/-^cells only RelB- and in *relB*^-/-^cells only RelA-containing κB-binding complexes were induced (Figure [1](#F1){ref-type="fig"}). Recently, slow and relatively weak DNA-binding of NF-κB complexes in response to LTβR ligation was reported \[[@B12]\]. The plateau was reached between 10 and 15 h of LTβR stimulation corresponding to a 2- to 3-fold induction of NF-κB DNA binding. Our results are in agreement with these observations: for each genotype the strongest induction of κB-binding complexes was observed at 10 h. For gene expression profiling we therefore used total RNA isolated from untreated (0 h) and 10 h agonistic anti-LTβR mAb treated wt, *relA*^-/-^, and *relB*^-/-^MEFs, assuming that stronger DNA-binding activity reflects stronger gene expression changes controlled by NF-κB transcription factor complexes.

![**Confirmation of LTβR stimulation: induction of RelA- and RelB-containing DNA-binding complexes**. Wild-type, *relA*^-/-^, and *relB*^-/-^MEFs were treated with agonistic anti-LTβR mAb for the indicated times and subsequently nuclear extracts were prepared and analyzed by EMSA for NF-κB DNA-binding activity using an Igκ oligo. Specific Igκ DNA-binding complexes are indicated by arrow (RelA-containing dimers) and arrowhead (RelB-containing dimers). Non-specific DNA binding complexes (ns, lower lane) serve as loading control. Supershift analysis was performed using pre-immune serum (pre-imm. serum), anti-RelA antibody (α-RelA Ab), and anti-RelB antibody (α-RelB Ab). Supershifted complexes are indicated by asterisk.](1471-2164-9-606-1){#F1}

Global gene expression in response to LTβR stimulation in MEFs
--------------------------------------------------------------

To identify RelA- and RelB-regulated genes after LTβR stimulation, we carried out microarray analysis using total RNA from the experiment described above hybridized to CodeLink UniSet Mouse 20K I bioarrays. For statistical analysis, different genotypes were analyzed separately and significantly differentially expressed genes between time points 0 h and 10 h were identified (*p*\< 0.05). The fold change (FC) threshold was determined from the minimal detectable fold change (MDFC) calculated by the CodeLink Expression Analysis v4.1 software (wt: 1.48; *relA*^-/-^: 1.54; *relB*^-/-^: 1.36). In response to LTβR stimulation, a total of 528 genes were regulated in wt cells. In line with the moderate NF-κB activation seen in the EMSAs the observed gene regulation was also modest: gene expression changes were in the range of +5-fold (induction) and -5-fold (repression). We assigned the 528 LTβR-responsive genes to 4 categories: genes that were significantly regulated (i) only in wt cells (category I, n = 366), (ii) in wt and *relA*^-/-^cells (category II, n = 30), (iii) in wt and *relB*^-/-^cells (category III, n = 102), and (iv) genes that were significantly regulated in all 3 genotypes (category IV, n = 30) (Figure [2A](#F2){ref-type="fig"}; for the list of LTβR-responsive genes in wt cells see Additional file [1](#S1){ref-type="supplementary-material"}).

![**LTβR-responsive genes can be allocated into distinct categories**. (A) Venn-diagram of significantly (*p*\< 0.05) regulated genes. (B) Schematic depiction of gene expression patterns. The four main categories in (A) can be segregated into further subcategories, depending on whether their genes were upregulated or downregulated. The arrows in the plots show the direction of gene expression changes from non-induced (0 h) to the 10 h induced state in response to LTβR stimulation. The first arrow describes gene expression behavior in wild-type, the second in *relA*^-/-^, and the third in *relB*^-/-^cells. Horizontal arrows indicate lack of change or statistically insignificant change in gene expression. Arrows pointing upwards or downwards indicate significant positive or negative regulation, respectively.](1471-2164-9-606-2){#F2}

The genes in these four categories could be segregated into further subcategories, which helped us to assign regulatory mechanisms underlying the expression patterns of individual genes (see schematic depiction of gene expression behavior in Figure [2B](#F2){ref-type="fig"} and lists of genes belonging to different subcategories in Additional files [2](#S2){ref-type="supplementary-material"}, [3](#S3){ref-type="supplementary-material"}, [4](#S4){ref-type="supplementary-material"}, [5](#S5){ref-type="supplementary-material"}).

Category (cat) I genes were significantly regulated only in wt cells in response to LTβR stimulation. This group of genes required both RelA and RelB for their LTβR-dependent activation (cat I/1, n = 161) or repression (cat I/2, n = 205). Therefore, expression of these genes did not significantly change in either of the mutant cell lines in response to agonistic anti-LTβR mAb treatment (Figure [2B](#F2){ref-type="fig"}, Additional file [2](#S2){ref-type="supplementary-material"}).

Category II genes were significantly regulated in wt and *relA*^-/-^cells upon LTβR ligation. Genes upregulated (cat II/1, n = 13) or downregulated (cat II/2, n = 17) in both wt and *relA*^-/-^cells, but not significantly regulated in *relB*^-/-^cells, were considered to be RelB target genes in response to LTβR signaling. Other theoretical patterns could also be appointed to category II, but we did not find any example in our analysis for these subcategories (cat II/3, n = 0 and cat II/4, n = 0) (Figure [2B](#F2){ref-type="fig"}, Additional file [3](#S3){ref-type="supplementary-material"}).

Genes belonging to category III were significantly regulated in wt and *relB*^-/-^cells in response to LTβR stimulation. Genes upregulated (cat III/1, n = 54) or downregulated (cat III/2, n = 43) in both wt and *relB*^-/-^cells, but not significantly regulated in *relA*^-/-^cells, were considered to be RelA target genes in response to LTβR signaling. Negligible numbers of genes in category III could also be allocated to cat III/3 and III/4 (n = 3 and n = 2, respectively) (Figure [2B](#F2){ref-type="fig"}, Additional file [4](#S4){ref-type="supplementary-material"}). However, these genes were not further analyzed. The significantly larger number of RelA- (cat III) compared to RelB-regulated genes (cat II; Figure [2A](#F2){ref-type="fig"}) is likely to be a consequence of the stronger LTβR-induced DNA binding of RelA compared to RelB complexes (Figure [1](#F1){ref-type="fig"}).

Category IV genes were significantly regulated in each of the genotypes in response to LTβR ligation. Although eight theoretically possible gene expression behaviors exist, we only found genes that belonged to two easily explainable scenarios: genes were either upregulated (cat IV/1, n = 20), or downregulated (cat IV/2, n = 10) in each genotype upon LTβR signaling (Figure [2B](#F2){ref-type="fig"}, Additional file [5](#S5){ref-type="supplementary-material"}). Most likely, both RelA and RelB contributed redundantly to their regulation or alternatively, a third factor/pathway controlled these genes in response to LTβR stimulation. JNK (c-Jun N-terminal kinase) is a possible candidate for such a third pathway, as there are indications that LTβR stimulation leads to activation of JNK. However, the experimental setup in those studies was different from ours as LTβR-overexpressing HEK293 cells \[[@B23]\] or treatment of MEFs with the LTβR agonist LIGHT (lymphotoxin-related inducible ligand that competes for glycoprotein D binding to herpesvirus entry mediator on T cells) \[[@B24]\] were studied.

FC values observed in the three cell lines at 10 h compared to 0 h are displayed in a heatmap that also reflects the four categories and their subcategories (Figure [3](#F3){ref-type="fig"}, for a zoomable/enlarged version of FC heatmaps supplied with gene symbols and GenBank Accession Numbers see Additional file [6](#S6){ref-type="supplementary-material"}).

![**Fold change heatmaps**. Heatmaps displaying the fold change values observed in the three different cell lines at 10 h compared to 0 h. The color code indicates the fold change values between -2.5-fold downregulation (green) and +2.5-fold upregulation (red). Fold change of -2.5 and below are depicted in the brightest green and fold change of +2.5 and above are shown in the brightest red. Black indicates no change in gene expression. Each horizontal line on the heatmap corresponds to one gene. Genes are arranged by their subcategory (see bars on the left) and main categories are divided by a horizontal white line.](1471-2164-9-606-3){#F3}

Interestingly, in the two subcategories with the largest number of genes both RelA and RelB together were required for LTβR-induced gene regulation (161 cat I/1 genes for their activation and 205 cat I/2 genes for their repression). In case one of the transcription factors was missing the other one was not able to ensure regulation alone, suggesting significant crosstalk between the two NF-κB activation pathways. In response to LTβR stimulation, sequential engagement of the classical and alternative pathway was suggested, resulting in initial DNA binding by RelA followed by RelB complexes \[[@B7],[@B9]\]. These findings may suggest a scenario where RelA binds first to the DNA in the promoter of category I genes, loosens up chromatin, thereby enabling subsequent DNA binding and gene regulatory action by RelB \[[@B25]\]. Alternatively, since *relB*is an NF-κB target gene \[[@B26]\] RelA may ensure sufficiently high expression of RelB and in the absence of RelA the reduced RelB levels cannot mediate proper regulation of certain LTβR target genes. This possibility is supported by the observation that in the absence of RelA both RelB protein levels and binding of RelB to κB sites were reduced (Figure [1](#F1){ref-type="fig"} and data not shown) \[[@B13]\].

Meta analysis of LTβR-dependent transcriptomes
----------------------------------------------

LTβR signaling is best known in the context of secondary lymphoid organ development and a recent expression profiling study described LTβR-dependent transcriptomes in lymph nodes and follicular dendritic cells (FDCs) \[[@B27]\]. However, increasing evidence suggests that LTβR also plays a role in non-lymphoid organs such as epithelial tissues during embryonic development \[[@B28]\] and adult liver \[[@B21],[@B22]\].

To interpret our results in the light of other studies investigating LTβR signaling, we compared our LTβR-responsive genes with two recently published LTβR-dependent transcriptomes. Huber *et al*. identified transcripts in murine mesenteric lymph nodes affected *in vivo*by the administration of a soluble LTβR-Ig decoy receptor which blocks LTβR signaling \[[@B27]\]. A gene cluster of 80 unique transcripts that showed decreased expression after LTβR blockade was further analyzed. Twelve genes in this cluster were also associated with germinal centers (GCs)/FDC. A few common genes were found between our analysis and the LTβR-dependent transcriptomes described by Huber *et al*. *Dclk1*and *enpp2*(doublecortin-like kinase 1; GenBank Accession Number: [NM_019978](NM_019978) and ectonucleotide pyrophosphatase/phosphodiesterase 2 or autotaxin; GenBank Accession Number: [NM_015744](NM_015744)) expression was moderately decreased 3 d after LTβR blockade (FC: 0.70× and 0.66×, respectively) \[[@B27]\]. In our hands, both genes were upregulated in response to LTβR stimulation in a RelA-dependent manner (cat III/1, for *enpp2*see also Table [12](#T12){ref-type="table"}). *Enpp2*was also found to be associated with GC/FDC in mesenteric lymph nodes \[[@B27]\]. Moreover, Enpp2 (also called autotaxin) has been recently described as a new molecule in lymphocyte homing through high endothelial venules (HEVs) \[[@B29]\]. Collectively, these findings suggest that LTβR, in addition to its well-described effect on the HEV differentiation program \[[@B30]\], further contributes via RelA-dependent upregulation of *enpp2*to lymphocyte homing through HEVs. Unfortunately, we could not detect further genes with a similar regulation pattern in our and Huber and colleagues\' studies. This lack of overlap could be the consequence of several reasons: (i) different modes of function and kinetics of antagonistic LTβR-Ig vs agonistic anti-LTβR mAb application, (ii) incubation time (3 d treatment with LTβR-Ig vs 10 h treatment with agonistic anti-LTβR mAb), or (iii) *in vivo*collection of different cell types influenced by the treatment vs *in vitro*cell culture system using MEFs.

Lo *et al*. described a hepatic gene expression profile of wt vs lck-LIGHT transgenic mice (overexpressing the LTβR ligand LIGHT on the surface of T lymphocytes) \[[@B22]\]. A group of significantly regulated genes (n = 19) involved in lipid and cholesterol metabolism was identified. The gene that displayed the highest level of regulation (23-fold repression in transgenic vs wt mice) encodes for hepatic lipase, a key enzyme in lipid metabolism. We did not observe repression of hepatic lipase in our experiments, most probably due to its restricted expression on the surface of hepatocytes. However, we found another gene belonging to the lipid/cholesterol metabolism-related group described by Lo and colleagues. *Ralgds*(ral guanine nucleotide dissociation stimulator, GenBank Accession Number: [NM_009058](NM_009058)) expression was increased in the liver of transgenic mice and also upregulated in our LTβR stimulation experiments, belonging to the RelA-responsive genes (cat III/1, Table [12](#T12){ref-type="table"}).

Gene Ontology (GO) enrichment analysis
--------------------------------------

Our goal was not only to define the LTβR-dependent transcriptome in MEFs, but also to assign regulatory mechanisms to LTβR signaling, i.e. to examine which part of the LTβR transcriptome is regulated by RelA, RelB, or both. We started out with GO enrichment analysis of significantly regulated genes to identify biological processes, molecular functions, and cellular components putatively regulated in the categories described above. Compared to molecular functions and cellular components, GO analysis of biological processes yielded the most conclusive results.

First, GO analysis was performed on the total LTβR transcriptome in wt cells to see how LTβR signaling influences biological processes in these fibroblasts, regardless whether these genes were also regulated in *relA*^-/-^or *relB*^-/-^cells (Category: Total wild-type, Table [1](#T1){ref-type="table"}). For interpretation of our data we chose GO terms with *p*\< 0.01. As lower limit, we did not consider GO terms with less than 3 annotated genes in the list of differentially regulated genes since they are too specific. As upper limit we did not use GO terms represented by more than 600 genes on the microarray since they are too general. Among the considered GO terms we found that apoptosis/cell death (A/CD)- and cell cycle (CCY)-related processes were overrepresented. We also found that genes annotated with \"response to biotic stimulus\", \"immune system process\" (immune related (IR) features) as well as \"blood vessel morphogenesis\" and \"angiogenesis\" (blood vessel development related (BR) features) were enriched. Collectively, these data indicate that LTβR signaling largely influences cell survival/cell proliferation features. Moreover, it has an impact on immune responses and blood vessel development/angiogenesis related processes. Since these GO terms were found in LTβR-stimulated \"non-immune\" fibroblasts it is likely that LTβR signaling regulates similar biological processes in stromal cells of secondary lymphoid tissues governing lymphorganogenesis and maintaining lymphoid tissue architecture.

###### 

Gene Ontology analysis of total LTβR transcriptome in wild-type cells

  **GO number**   **GO term**                                    **Type of biological process**   ***p*value**   **n sel**.   **n tot**.
  --------------- ---------------------------------------------- -------------------------------- -------------- ------------ ------------
  GO:0007049      Cell cycle                                     CCY                              1.80E-05       39           559
                                                                                                                              
  GO:0006915      Apoptosis                                      A/CD                             1.00E-04       34           499
                                                                                                                              
  GO:0008219      Cell death                                     A/CD                             0.00011        35           523
                                                                                                                              
  GO:0016265      Death                                          A/CD                             0.00011        35           523
                                                                                                                              
  GO:0012501      Programmed cell death                          A/CD                             0.00012        34           503
                                                                                                                              
  GO:0006259      DNA metabolic process                          CCY                              0.00016        32           469
                                                                                                                              
  GO:0022402      Cell cycle process                             CCY                              0.00034        30           447
                                                                                                                              
  GO:0042981      Regulation of apoptosis                        A/CD                             0.00063        23           319
                                                                                                                              
  GO:0043067      Regulation of programmed cell death            A/CD                             0.00068        23           321
                                                                                                                              
  GO:0009607      Response to biotic stimulus                    IR                               0.0035         11           124
                                                                                                                              
  GO:0006260      DNA replication                                CCY                              0.0037         10           107
                                                                                                                              
  GO:0043066      Negative regulation of apoptosis               A/CD                             0.0045         11           128
                                                                                                                              
  GO:0000074      Regulation of progression through cell cycle   CCY                              0.0047         19           287
                                                                                                                              
  GO:0043069      Negative regulation of programmed cell death   A/CD                             0.0048         11           129
                                                                                                                              
  GO:0051726      Regulation of cell cycle                       CCY                              0.0051         19           289
                                                                                                                              
  GO:0002376      Immune system process                          IR                               0.0053         30           534
                                                                                                                              
  GO:0030968      Unfolded protein response                                                       0.0054         3            11
                                                                                                                              
  GO:0007610      Behavior                                                                        0.0054         17           249
                                                                                                                              
  GO:0009953      Dorsal/ventral pattern formation                                                0.0057         5            37
                                                                                                                              
  GO:0016567      Protein ubiquitination                                                          0.0064         5            35
                                                                                                                              
  GO:0006730      One-carbon compound metabolic process                                           0.0067         7            65
                                                                                                                              
  GO:0048514      Blood vessel morphogenesis                     BR                               0.0078         12           157
                                                                                                                              
  GO:0040029      Regulation of gene expression, epigenetic                                       0.0082         5            37
                                                                                                                              
  GO:0007631      Feeding behavior                                                                0.0084         4            24
                                                                                                                              
  GO:0001525      Angiogenesis                                   BR                               0.0087         10           121
                                                                                                                              
  GO:0006171      cAMP biosynthetic process                                                       0.0089         3            13
                                                                                                                              
  GO:0051094      Positive regulation of developmental process                                    0.0092         6            53

Analysis of functional enrichment was performed employing Fisher\'s exact test. The number of genes annotated with a specific GO term was determined for the list of differentially expressed genes (n sel.) and compared to all GO annotated genes on the array (n tot.). The resulting *p*values (*p*\< 0.01) were used to rank GO terms according to their significance. Terms with more than 600 genes on the array or less than 3 genes on the list of investigated genes were regarded as too general or too specific, respectively, and excluded from the analysis. A/CD, apoptosis/cell death; CCY, cell cycle; IR, immune related; BR, blood vessel development related.

Next, we carried out GO analysis for the four main categories and for all subcategories with at least 20 genes. Interpretation of the data was performed applying the same criteria as above. GO analysis of category I genes revealed those biological processes that were overrepresented only in LTβR-stimulated wt cells, i.e. in the presence of both RelA and RelB (Table [2](#T2){ref-type="table"}). Amongst these processes, CCY-related terms dominated. Subsequently, we analyzed cat I/1 (containing genes that were upregulated exclusively in wt cells) and found enrichment of IR- and cell/biological adhesion (important events in immune cell migration)-related terms on the list of biological processes (Table [3](#T3){ref-type="table"}). This finding indicates that in the absence of RelA or RelB a considerable portion of LTβR-stimulated immune response-related events cannot be carried out; fibroblasts need both molecules to execute these processes. In cat I/2 (containing genes that are downregulated exclusively in wt cells) we found enrichment of CCY-related terms on the list of overrepresented biological processes (Table [4](#T4){ref-type="table"}). This finding indicates that in wt cells an important action of RelA and RelB is to downregulate numerous genes that are implicated in cell cycle regulation in response to LTβR signaling.

###### 

Gene Ontology analysis of category I

  **GO number**   **GO term**                                 **Type of biological process**   ***p*value**   **n sel**.   **n tot**.
  --------------- ------------------------------------------- -------------------------------- -------------- ------------ ------------
  GO:0006259      DNA metabolic process                       CCY                              1.40E-05       27           469
                                                                                                                           
  GO:0007049      Cell cycle                                  CCY                              1.80E-05       30           559
                                                                                                                           
  GO:0022402      Cell cycle process                          CCY                              0.00033        23           447
                                                                                                                           
  GO:0040029      Regulation of gene expression, epigenetic                                    0.0016         5            37
                                                                                                                           
  GO:0006260      DNA replication                             CCY                              0.0036         8            107
                                                                                                                           
  GO:0022403      Cell cycle phase                            CCY                              0.0041         12           211
                                                                                                                           
  GO:0006730      One-carbon compound metabolic process                                        0.0041         6            65
                                                                                                                           
  GO:0051301      Cell division                               CCY                              0.0045         11           187
                                                                                                                           
  GO:0031497      Chromatin assembly                                                           0.0047         5            47
                                                                                                                           
  GO:0016458      Gene silencing                                                               0.0068         3            17
                                                                                                                           
  GO:0009953      Dorsal/ventral pattern formation                                             0.0079         4            34
                                                                                                                           
  GO:0043543      Protein amino acid acylation                                                 0.008          3            18
                                                                                                                           
  GO:0000278      Mitotic cell cycle                          CCY                              0.0081         10           175
                                                                                                                           
  GO:0016567      Protein ubiquitination                                                       0.0087         4            35

GO analysis was performed the same way as for category \"total wild-type\" described in Table 1 legend. CCY, cell cycle.

###### 

Gene Ontology analysis of category I/1

  **GO number**   **GO term**                   **Type of biological process**   ***p*value**   **n sel**.   **n tot**.
  --------------- ----------------------------- -------------------------------- -------------- ------------ ------------
  GO:0045087      Innate immune response        IR                               0.0027         4            58
                                                                                                             
  GO:0002526      Acute inflammatory response   IR                               0.0037         4            63
                                                                                                             
  GO:0007155      Cell adhesion                 IR                               0.0054         11           447
                                                                                                             
  GO:0022610      Biological adhesion           IR                               0.0054         11           447

GO analysis was performed the same way as for category \"total wild-type\" described in Table 1 legend. IR, immune related.

###### 

Gene Ontology analysis of category I/2

  **GO number**   **GO term**                                                                **Type of biological process**   ***p*value**   **n sel**.   **n tot**.
  --------------- -------------------------------------------------------------------------- -------------------------------- -------------- ------------ ------------
  GO:0007049      Cell cycle                                                                 CCY                              3.10E-07       24           559
                                                                                                                                                          
  GO:0006259      DNA metabolic process                                                      CCY                              9.50E-07       21           469
                                                                                                                                                          
  GO:0022402      Cell cycle process                                                         CCY                              7.00E-06       19           447
                                                                                                                                                          
  GO:0022403      Cell cycle phase                                                           CCY                              2.40E-05       12           211
                                                                                                                                                          
  GO:0051301      Cell division                                                              CCY                              3.90E-05       11           187
                                                                                                                                                          
  GO:0000278      Mitotic cell cycle                                                         CCY                              0.00011        10           175
                                                                                                                                                          
  GO:0006730      One-carbon compound metabolic process                                                                       0.00022        6            65
                                                                                                                                                          
  GO:0006468      Protein amino acid phosphorylation                                                                          0.00025        17           487
                                                                                                                                                          
  GO:0006260      DNA replication                                                            CCY                              0.00055        7            107
                                                                                                                                                          
  GO:0000279      M phase                                                                    CCY                              0.00057        9            176
                                                                                                                                                          
  GO:0016310      Phosphorylation                                                                                             0.00076        17           536
                                                                                                                                                          
  GO:0009953      Dorsal/ventral pattern formation                                                                            0.001          4            34
                                                                                                                                                          
  GO:0040029      Regulation of gene expression, epigenetic                                                                   0.0014         4            37
                                                                                                                                                          
  GO:0007067      Mitosis                                                                    CCY                              0.0015         7            126
                                                                                                                                                          
  GO:0000087      M phase of mitotic cell cycle                                              CCY                              0.0015         7            127
                                                                                                                                                          
  GO:0043543      Protein amino acid acylation                                                                                0.0016         3            18
                                                                                                                                                          
  GO:0007224      Smoothened signaling pathway                                                                                0.0038         3            24
                                                                                                                                                          
  GO:0006913      Nucleocytoplasmic transport                                                                                 0.004          5            79
                                                                                                                                                          
  GO:0051169      Nuclear transport                                                                                           0.004          5            79
                                                                                                                                                          
  GO:0007178      Transmembrane receptor protein serine/threonine kinase signaling pathway                                    0.0083         4            60
                                                                                                                                                          
  GO:0022613      Ribonucleoprotein complex biogenesis and assembly                                                           0.0093         6            135
                                                                                                                                                          
  GO:0035295      Tube development                                                                                            0.0096         6            136

GO analysis was performed the same way as for category \"total wild-type\" described in Table 1 legend. CCY, cell cycle.

Since cat II/1 and II/2 had only few genes (n = 13 and n = 17, respectively), investigation of GO terms for these groups of genes was not meaningful. GO analysis of the main category II (containing genes that were regulated -- either up or down -- in wt and *relA*^-/-^cells, n = 30) revealed only one enriched GO term, the cell cycle (Table [5](#T5){ref-type="table"}). Thus, in response to LTβR signaling a characteristic feature of RelB was to influence cell cycle-related events.

###### 

Gene Ontology analysis of category II

  **GO number**   **GO term**   **Type of biological process**   ***p*value**   **n sel**.   **n tot**.
  --------------- ------------- -------------------------------- -------------- ------------ ------------
  GO:0007049      Cell cycle    CCY                              0.0059         5            559

GO analysis was performed the same way as for category \"total wild-type\" described in Table 1 legend. CCY, cell cycle.

Category III contains genes that were regulated -- either up or down -- in wt and *relB*^-/-^cells in response to LTβR stimulation. Among enriched biological processes, the new and in previous categories not yet observed theme taxis and response to external/chemical stimulus (T) dominated, but A/CD-related events also appeared (Table [6](#T6){ref-type="table"}). As expected, the theme IR was also represented among the enriched biological processes. This shows that RelA is not only a signal transducer for immune responses and apoptosis/cell death, but also has an impact on the transcription of taxis- and stimulus-responsive genes following LTβR ligation. Among the enriched biological processes of cat III/1 we observed again overrepresentation of T and IR processes (Table [7](#T7){ref-type="table"}), revealing that in response to LTβR signaling RelA strongly influenced these events via upregulation of several genes. In cat III/2 we found genes that were repressed by RelA. In this subcategory RelA on one hand regulated several BR events. On the other hand, it turned out to be a negative regulator of genes involved in ion homeostasis (ION) downstream of the LTβR (Table [8](#T8){ref-type="table"}).

###### 

Gene Ontology analysis of category III

  **GO number**   **GO term**                                   **Type of biological process**   ***p*value**   **n sel**.   **n tot**.
  --------------- --------------------------------------------- -------------------------------- -------------- ------------ ------------
  GO:0006939      Smooth muscle contraction                                                      0.00018        3            16
                                                                                                                             
  GO:0048675      Axon extension                                                                 0.00027        3            18
                                                                                                                             
  GO:0006935      Chemotaxis                                    T                                0.00058        5            95
                                                                                                                             
  GO:0042330      Taxis                                         T                                0.00058        5            95
                                                                                                                             
  GO:0009605      Response to external stimulus                 T                                0.0011         9            364
                                                                                                                             
  GO:0006936      Muscle contraction                                                             0.0011         4            64
                                                                                                                             
  GO:0007610      Behavior                                      T                                0.002          7            249
                                                                                                                             
  GO:0048858      Cell projection morphogenesis                                                  0.003          6            200
                                                                                                                             
  GO:0032990      Cell part morphogenesis                                                        0.003          6            200
                                                                                                                             
  GO:0030030      Cell projection organization and biogenesis                                    0.003          6            200
                                                                                                                             
  GO:0007626      Locomotory behavior                           T                                0.0072         5            169
                                                                                                                             
  GO:0042981      Regulation of apoptosis                       A/CD                             0.0077         7            319
                                                                                                                             
  GO:0043067      Regulation of programmed cell death           A/CD                             0.0079         7            321
                                                                                                                             
  GO:0042221      Response to chemical stimulus                 T                                0.0082         7            323
                                                                                                                             
  GO:0006915      Apoptosis                                     A/CD                             0.009          9            499
                                                                                                                             
  GO:0012501      Programmed cell death                         A/CD                             0.0094         9            503
                                                                                                                             
  GO:0048522      Positive regulation of cellular process                                        0.0096         10           596
                                                                                                                             
  GO:0006955      Immune response                               IR                               0.0097         7            334

GO analysis was performed the same way as for category \"total wild-type\" described in Table 1 legend. T, taxis, response to external/chemical stimulus; A/CD, apoptosis/cell death; IR, immune related.

###### 

Gene Ontology analysis of category III/1

  **GO number**   **GO term**                     **Type of biological process**   ***p*value**   **n sel**.   **n tot**.
  --------------- ------------------------------- -------------------------------- -------------- ------------ ------------
  GO:0006955      Immune response                 IR                               2.00E-04       7            334
                                                                                                               
  GO:0009605      Response to external stimulus   T                                0.00034        7            364
                                                                                                               
  GO:0006935      Chemotaxis                      T                                0.00041        4            95
                                                                                                               
  GO:0042330      Taxis                           T                                0.00041        4            95
                                                                                                               
  GO:0002376      Immune system process           IR                               0.00065        8            534
                                                                                                               
  GO:0007610      Behavior                        T                                0.0022         5            249
                                                                                                               
  GO:0007626      Locomotory behavior             T                                0.0035         4            169
                                                                                                               
  GO:0006954      Inflammatory response           IR                               0.0036         4            171
                                                                                                               
  GO:0006952      Defense response                IR                               0.0052         5            305
                                                                                                               
  GO:0002252      Immune effector process         IR                               0.0064         3            102
                                                                                                               
  GO:0042221      Response to chemical stimulus   T                                0.0066         5            323

GO analysis was performed the same way as for category \"total wild-type\" described in Table 1 legend. IR, immune related; T, taxis, response to external/chemical stimulus.

###### 

Gene Ontology analysis of category III/2

  **GO number**   **GO term**                                             **Type of biological process**   ***p*value**   **n sel**.   **n tot**.
  --------------- ------------------------------------------------------- -------------------------------- -------------- ------------ ------------
  GO:0006939      Smooth muscle contraction                                                                1.40E-05       3            16
                                                                                                                                       
  GO:0006936      Muscle contraction                                                                       3.90E-05       4            64
                                                                                                                                       
  GO:0001525      Angiogenesis                                            BR                               0.00046        4            121
                                                                                                                                       
  GO:0048514      Blood vessel morphogenesis                              BR                               0.0012         4            157
                                                                                                                                       
  GO:0048646      Anatomical structure formation                          BR                               0.0012         4            159
                                                                                                                                       
  GO:0030005      Cellular di-, tri-valent inorganic cation homeostasis   ION                              0.0016         3            77
                                                                                                                                       
  GO:0055066      Di-, tri-valent inorganic cation homeostasis            ION                              0.0017         3            78
                                                                                                                                       
  GO:0008015      Circulation                                             BR                               0.0017         3            79
                                                                                                                                       
  GO:0030003      Cellular cation homeostasis                             ION                              0.0021         3            84
                                                                                                                                       
  GO:0001568      Blood vessel development                                BR                               0.0021         4            182
                                                                                                                                       
  GO:0055080      Cation homeostasis                                      ION                              0.0021         3            85
                                                                                                                                       
  GO:0006873      Cellular ion homeostasis                                ION                              0.0022         3            86
                                                                                                                                       
  GO:0055082      Cellular chemical homeostasis                           ION                              0.0022         3            86
                                                                                                                                       
  GO:0001944      Vasculature development                                 BR                               0.0023         4            185
                                                                                                                                       
  GO:0050801      Ion homeostasis                                         ION                              0.003          3            96
                                                                                                                                       
  GO:0065008      Regulation of biological quality                                                         0.004          5            354
                                                                                                                                       
  GO:0065008      Chemical homeostasis                                    ION                              0.0062         3            124
                                                                                                                                       
  GO:0007507      Heart development                                       BR                               0.0088         3            141

GO analysis was performed the same way as for category \"total wild-type\" described in Table 1 legend. BR, blood vessel development related; ION, ion homeostasis.

Category IV contains genes that were regulated -- either up or down -- in each of the cell types in response to LTβR stimulation (Table [9](#T9){ref-type="table"}). IR processes were overrepresented, but the terms related to hematopoietic or lymphoid organ development (LY) and taxis (T) were also present on the list of enriched biological processes. Unfortunately, we could not analyze cat IV/2, as it comprises too few genes (n = 10). Cat IV/1 contains 20 genes that were upregulated, irrespective of the genotype (Table [10](#T10){ref-type="table"}). These genes primarily belong to IR and T. Possibly, RelA and RelB redundantly regulate these events or alternatively a RelA- and RelB-independent third factor/pathway (e.g. JNK) controls these biological processes following LTβR ligation. Table [11](#T11){ref-type="table"} shows a summary of our GO analysis.

###### 

Gene Ontology analysis of category IV

  **GO number**   **GO term**                                 **Type of biological process**   ***p*value**   **n sel**.   **n tot**.
  --------------- ------------------------------------------- -------------------------------- -------------- ------------ ------------
  GO:0002376      Immune system process                       IR                               4.40E-05       7            534
                                                                                                                           
  GO:0006955      Immune response                             IR                               0.00038        5            334
                                                                                                                           
  GO:0045595      Regulation of cell differentiation                                           0.0013         3            113
                                                                                                                           
  GO:0006952      Defense response                            IR                               0.0026         4            305
                                                                                                                           
  GO:0042221      Response to chemical stimulus               T                                0.0032         4            323
                                                                                                                           
  GO:0006954      Inflammatory response                       IR                               0.0043         3            171
                                                                                                                           
  GO:0048534      Hemopoietic or lymphoid organ development   LY                               0.0064         3            197
                                                                                                                           
  GO:0050793      Regulation of developmental process                                          0.0067         3            201
                                                                                                                           
  GO:0002520      Immune system development                   IR                               0.0078         3            212

GO analysis was performed the same way as for category \"total wild-type\" described in Table 1 legend. IR, immune related; T, taxis, response to external/chemical stimulus; LY, hematopoietic or lymphoid organ developmental processes.

###### 

Gene Ontology analysis of category IV/1

  **GO number**   **GO term**                             **Type of biological process**   ***p*value**   **n sel**.   **n tot**.
  --------------- --------------------------------------- -------------------------------- -------------- ------------ ------------
  GO:0002376      Immune system process                   IR                               1.40E-05       6            534
                                                                                                                       
  GO:0006955      Immune response                         IR                               2.4E-05        5            334
                                                                                                                       
  GO:0006952      Defense response                        IR                               0.00032        4            305
                                                                                                                       
  GO:0006954      Inflammatory response                   IR                               0.00091        3            171
                                                                                                                       
  GO:0009611      Response to wounding                    IR                               0.0024         3            240
                                                                                                                       
  GO:0015031      Protein transport                                                        0.0024         4            523
                                                                                                                       
  GO:0045184      Establishment of protein localization                                    0.0029         4            546
                                                                                                                       
  GO:0008104      Protein localization                                                     0.0037         4            586
                                                                                                                       
  GO:0042221      Response to chemical stimulus           T                                0.0056         3            323
                                                                                                                       
  GO:0006886      Intracellular protein transport                                          0.0057         3            326
                                                                                                                       
  GO:0009605      Response to external stimulus           T                                0.0078         3            364

GO analysis was performed the same way as for category \"total wild-type\" described in Table 1 legend. IR, immune related; T, taxis, response to external/chemical stimulus.

###### 

Summary of Gene Ontology analysis results

  ------------------------------------------------------------------------------------------------------------------------------------------------------
  **Category/Subcategory**   **Enriched biological processes**   **Regulatory molecules downstream of LTβR, and their effects on the gene expression**
  -------------------------- ----------------------------------- ---------------------------------------------------------------------------------------
  Total wild-type            A/CD\                               Molecules not assignable -- up and downregulation
                             CCY\                                
                             IR\                                 
                             BR                                  

                                                                 

  Cat I                      CCY                                 RelA and RelB together -- up and downregulation

                                                                 

  Cat I/1                    IR                                  RelA and RelB together -- upregulation

                                                                 

  Cat I/2                    CCY                                 RelA and RelB together -- downregulation

                                                                 

  Cat II                     CCY                                 RelB -- up and downregulation

                                                                 

  Cat II/1                   Not investigated                    RelB -- upregulation

                                                                 

  Cat II/2                   Not investigated                    RelB -- downregulation

                                                                 

  Cat III                    T\                                  RelA -- up and downregulation
                             A/CD\                               
                             IR                                  

                                                                 

  Cat III/1                  T\                                  RelA -- upregulation
                             IR                                  

                                                                 

  Cat III/2                  ION\                                RelA -- downregulation
                             BR                                  

                                                                 

  Cat IV                     IR\                                 RelA and RelB via redundant effects -- up and downregulation\
                             T\                                  **OR**\
                             LY                                  Third pathway -- up and downregulation

                                                                 

  Cat IV/1                   IR\                                 RelA and RelB via redundant effects -- upregulation\
                             T                                   **OR**\
                                                                 Third pathway -- upregulation

                                                                 

  Cat IV/2                   Not investigated                    RelA and RelB via redundant effects -- downregulation\
                                                                 **OR**\
                                                                 Third pathway -- downregulation
  ------------------------------------------------------------------------------------------------------------------------------------------------------

Summary of GO analysis: categories/subcategories with their respective enriched biological processes and the assigned regulatory mechanisms are listed. A/CD, apoptosis/cell death; CCY, cell cycle; IR, immune related; BR, blood vessel development related; T, taxis, response to external/chemical stimulus; ION, ion homeostasis; LY, hematopoietic or lymphoid organ developmental processes. Since cat II/1, II/2 and cat IV/2 had only few genes (n = 13, 17 and 10, respectively) they were not investigated for GO terms.

Verification of microarray results by qRT-PCR
---------------------------------------------

The changes in mRNA levels of several known as well as novel LTβR-responsive genes on the microarray were confirmed by quantitative real-time reverse-transcription-PCR (qRT-PCR), using RNA from three independent LTβR stimulation experiments (Table [12](#T12){ref-type="table"}). In agreement with previous reports, we also found induction of *nfkb2*\[[@B5],[@B6]\], *ccl2/mcp1*\[[@B6]\], and *ikba*expression \[[@B31]\] in LTβR-stimulated wt fibroblasts. In addition, our data indicate that both RelA and RelB redundantly contributed to the proper regulation of these genes in response to LTβR stimulation. However, we did not observe LTβR-dependent upregulation of lymphorganogenic chemokines as described by others. *Ccl21*, *ccl19*, *cxcl13*, and *cxcl12*were shown to be LTβR-induced genes in spleen 8 h after peritoneal injection of an agonistic anti-LTβR mAb \[[@B5]\]. Possibly, cell context-specific signaling accounts for the difference observed between splenocytes and established 3T3 fibroblasts used in our experiments. Basak *et al*. observed modest upregulation of *cxcl13*and *ccl21*in established wt 3T3 fibroblasts after 24 h treatment with agonistic anti-LTβR mAb \[[@B13]\]. To reduce indirect gene regulatory effects due to rather long stimulation we activated LTβR signaling only for 10 h, where modulation of these chemokines was not observed.

###### 

Verification of microarray results by qRT-PCR

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Gene Symbol and GenBank Accession Number**   **CodeLink bioarrays FC and *p*value (in brackets) for wt/*relA*^-/-^/*relB*^-/-^cells and corresponding subcategory**   **qRT-PCR FC ± SD for wt/*relA*^-/-^/*relB*^-/-^cells and corresponding subcategory**
  ---------------------------------------------- ------------------------------------------------------------------------------------------------------------------------ ---------------------------------------------------------------------------------------
  **Cx3cl1**\                                    1.77 (0.00370)/0.90 (\>0.05)/0.96 (\>0.05), **I/1**                                                                      1.66 ± 0.22/0.89 ± 0.10/1.08 ± 0.29, **I/1**
  [NM_009142](NM_009142)                                                                                                                                                  

                                                                                                                                                                          

  **Pparg**\                                     0.65 (0.00690)/0.55 (0.01800)/1.32 (\>0.05), **II/2**                                                                    0.50 ± 0.02/0.48 ± 0.04/0.81 ± 0.11, **II/2**
  [NM_011146](NM_011146)                                                                                                                                                  

                                                                                                                                                                          

  Ralgds \*\                                     2.24 (0.00750)/1.48 (\>0.05)/1.58 (0.00140), **III/1**                                                                   2.03 ± 0.42/1.13 ± 0.10/1.17 ± 0.16, **I/1 -- not verified in *relB*^-/-^cells**
  [NM_009058](NM_009058)                                                                                                                                                  

                                                                                                                                                                          

  Enpp2 \*\                                      2.28 (0.00150)/1.36 (\>0.05)/5.10 (0.00070), **III/1**                                                                   1.85 ± 0.30/1.35 ± 0.27/3.29 ± 0.91, **III/1**
  [NM_015744](NM_015744)                                                                                                                                                  

                                                                                                                                                                          

  Birc3\                                         2.77 (0.00090)/1.34 (\>0.05)/2.94 (0.00140), **III/1**                                                                   2.86 ± 0.73/1.27 ± 0.11/2.99 ± 0.47, **III/1**
  [NM_007464](NM_007464)                                                                                                                                                  

                                                                                                                                                                          

  **Cxcl10/IP10**\                               1.91 (0.00450)/0.58 (\>0.05)/2.14 (0.03000), **III/1**                                                                   2.58 ± 0.21/1.28 ± 0.39/2.67 ± 0.20, **III/1**
  [NM_021274](NM_021274)                                                                                                                                                  

                                                                                                                                                                          

  Irf1\                                          1.96 (0.00270)/2.05 (\>0.05)/2.90 (0.00075), **III/1**                                                                   2.67 ± 0.32/1.77 ± 0.77/2.15 ± 0.19, **III/1**
  [NM_008390](NM_008390)                                                                                                                                                  

                                                                                                                                                                          

  **Cd74**\                                      3.11 (0.00300)/0.82 (\>0.05)/3.46 (0.00070), **III/1**                                                                   5.01 ± 0.99/1.06 ± 0.18/4.77 ± 0.56, **III/1**
  [NM_010545](NM_010545)                                                                                                                                                  

                                                                                                                                                                          

  Fosl1\                                         0.49 (0.00290)/0.86 (\>0.05)/0.42 (0.00070), **III/2**                                                                   0.46 ± 0.09/0.90 ± 0.09/0.47 ± 0.10, **III/2**
  [NM_010235](NM_010235)                                                                                                                                                  

                                                                                                                                                                          

  **Nfkb2**\                                     2.18 (0.0029)/1.57 (0.0016)/1.81 (0.0007), **IV/1**                                                                      2.04 ± 0.37/2.43 ± 0.50/2.74 ± 0.54, **IV/1**
  [NM_019408](NM_019408)                                                                                                                                                  

                                                                                                                                                                          

  **Ccl2/MCP1**\                                 2.10 (0.00120)/2.84 (0.0011)/2.99 (0.00099), **IV/1**                                                                    2.29 ± 0.42/3.18 ± 0.13/6.31 ± 1.63, **IV/1**
  [NM_011333](NM_011333)                                                                                                                                                  

                                                                                                                                                                          

  **Nfkbia/IκBα**\                               2.00 (0.00064)/2.19 (0.00270)/3.42 (0.00140), **IV/1**                                                                   1.77 ± 0.16/2.44 ± 0.34/3.92 ± 0.42, **IV/1**
  [NM_010907](NM_010907)                                                                                                                                                  

                                                                                                                                                                          

  **Ccl7/MCP3**\                                 2.22 (0.00041)/1.99 (0.04700)/4.35 (0.00140), **IV/1**                                                                   2.77 ± 0.13/3.15 ± 0.15/5.29 ± 1.68, **IV/1**
  [NM_013654](NM_013654)                                                                                                                                                  

                                                                                                                                                                          

  Cxcl1/KC\                                      2.40 (0.00580)/1.77 (0.01600)/1.80 (0.00160), **IV/1**                                                                   2.40 ± 0.46/1.31 ± 0.61/3.41 ± 0.88, **III/1 -- not verified in *relA*^-/-^cells**
  [NM_008176](NM_008176)                                                                                                                                                  

                                                                                                                                                                          

  Id2\                                           0.42 (0.00440)/0.60 (0.04000)/0.39 (0.00075), **IV/2**                                                                   0.47 ± 0.11/0.75 ± 0.05/0.57 ± 0.14, **IV/2**
  [NM_010496](NM_010496)                                                                                                                                                  
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

qRT-PCR using RNA from 3 independent LTβR stimulation experiments confirmed changes in mRNA levels of several known as well as novel LTβR-responsive genes on the microarray. Gene names (Gene Symbol) and GenBank Accesion Numbers are shown in the first column. FC values with corresponding *p*values in brackets, observed in the 3 cell lines (wt; *relA*^-/-^; *relB*^-/-^) at 10 h with CodeLink bioarrays and corresponding subcategories (in bold) are displayed in the second column. FC values with corresponding standard deviations (SD), observed in the 3 cell lines (wt; *relA*^-/-^; *relB*^-/-^) at 10 h with qRT-PCR using RNA from 3 independent LTβR stimulation experiments and corresponding subcategories (in bold) are displayed in the third column. Genes that are discussed in chapter \"Meta analysis of LTβR-dependent transcriptomes\" are indicated by an asterisk and genes that are discussed in chapter \"Verification of microarray results by qRT-PCR\" are listed in bold.

###### 

LTβR responsive qRT-PCR verified genes in literature

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Gene Symbol and GenBank Accession Number**   **LTβR responsiveness**\                   **In response to LTβR stimulation, transcription is regulated by RelA or RelB, + or - or 0 manner**„reference" if known/„this study" if new
                                                 „reference" if known/„this study" if new   
  ---------------------------------------------- ------------------------------------------ ---------------------------------------------------------------------------------------------------------------------------------------------
  **Cx3cl1**\                                    This study                                 \+ regulation by RelA and RelB **together**, this study
  [NM_009142](NM_009142)                                                                    

                                                                                            

  **Pparg**\                                     This study                                 0 RelA, this study\
  [NM_011146](NM_011146)                                                                    - RelB, this study

                                                                                            

  Ralgds \*\                                     Lo *et al*., 2007 \[[@B22]\]               Mode of regulation uncertain: RelA either alone, or together with RelB enhances Ralgds expression.
  [NM_009058](NM_009058)                                                                    

                                                                                            

  Enpp2 \*\                                      Huber *et al*., 2005 \[[@B27]\]            \+ RelA, this study\
  [NM_015744](NM_015744)                                                                    0 RelB, this study

                                                                                            

  Birc3\                                         This study                                 \+ RelA, this study\
  [NM_007464](NM_007464)                                                                    0 RelB, this study

                                                                                            

  **Cxcl10/IP10**\                               Lukashev *et al*., 2006 \[[@B34]\]         \+ RelA, this study\
  [NM_021274](NM_021274)                                                                    0 RelB, this study

                                                                                            

  Irf1\                                          Kutsch *et al*., 2008 \[[@B41]\]           \+ RelA, this study\
  [NM_008390](NM_008390)                                                                    0 RelB, this study

                                                                                            

  **Cd74**\                                      This study                                 \+ RelA, this study\
  [NM_010545](NM_010545)                                                                    0 RelB, this study

                                                                                            

  Fosl1\                                         This study                                 \- RelA, this study\
  [NM_010235](NM_010235)                                                                    0 RelB, this study

                                                                                            

  **Nfkb2**\                                     Dejardin *et al*., 2002 \[[@B5]\]\         \+ RelA, Dejardin *et al*., 2002 \[[@B5]\]\
  [NM_019408](NM_019408).1                       Derudder *et al*., 2003 \[[@B6]\]          + RelB, this study

                                                                                            

  **Ccl2/MCP1**\                                 Derudder *et al*., 2003 \[[@B6]\]          \+ RelA, this study\
  [NM_011333](NM_011333)                                                                    + RelB, this study

                                                                                            

  **Nfkbia/IκBα**\                               Bonizzi *et al*., 2004 \[[@B31]\]          \+ RelA, this study\
  [NM_010907](NM_010907)                                                                    + RelB, this study

                                                                                            

  **Ccl7/MCP3**\                                 This study                                 \+ RelA, this study\
  [NM_013654](NM_013654)                                                                    + RelB, this study

                                                                                            

  Cxcl1/KC\                                      This study                                 \+ RelA, this study\
  [NM_008176](NM_008176)                                                                    Positive regulation by RelB is uncertain.

                                                                                            

  Id2\                                           This study                                 \- RelA, this study\
  [NM_010496](NM_010496)                                                                    - RelB, this study
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Genes that are discussed in chapter \"Meta analysis of LTβR-dependent transcriptomes\" are indicated by an asterisk and genes that are discussed in chapter \"Verification of microarray results by qRT-PCR\" are listed in bold.

Importantly, we verified novel LTβR-responsive genes and appointed regulatory molecules to them. For a complete list of verified genes see Table [12](#T12){ref-type="table"}. Here, some of those verified genes are discussed in more detail.

GO analysis revealed that LTβR stimulation resulted in the regulation of IR processes (Table [11](#T11){ref-type="table"}). Except category \"Total wild-type\", where we could not assign regulatory molecules, in all categories where IR processes were enriched, RelA alone or together with RelB acted as a positive factor. *Cx3cl1*(chemokine C-X3-C motif ligand 1/fractalkine) is one of the IR genes in cat I/1. Several studies document that NF-κB upregulates *cx3cl1*, e.g. in rat aortic endothelial cells upon interleukin-1β (IL-1β), TNF, and lipopolysaccharide treatment \[[@B32]\] or in human coronary artery smooth muscle cells \[[@B33]\]. The latter work shows that atherogenic lipids induce adhesion of artery smooth muscle cells to macrophages via the upregulation of *cx3cl1*in a TNF/NF-κB-dependent manner. In our experiments this gene was upregulated in response to LTβR stimulation dependent on RelA and RelB. This data suggests that LTβR, via employing RelA and RelB together, may act as a proatherogenic factor.

IR- and T-related processes were also enriched in cat III and cat III/1 according to the GO analysis. *Cd74/ii*(invariant polypeptide of major histocompatibility complex, class II antigen-associated) and *cxcl10/ip10*(chemokine C-X-C motif ligand 10/interferon-inducible protein-10) are two genes in cat III/1 and assigned to IR and T. CD74/Ii is involved in antigen processing and presentation and CXCL10 is chemotactic for monocytes and T cells. Moreover, expression of CXCL10, along with two other CXCR3-binding chemokines CXCL9 and CXCL11, can be induced in carcinoma cells by LTβR agonists. These chemokines function as potent chemoattractants for activated T, NK, and dendritic cells, which may contribute to antitumor immune responses \[[@B34]\]. In our experiments, expression of *cd74/ii*and *cxcl10/ip10*was upregulated by LTβR signaling in wt and *relB*^-/-^cells. Thus, LTβR signaling via RelA may (i) attract T lymphocytes and promote antigen presentation by dendritic cells in the context of MHC class II and (ii) facilitate antitumor responses against cancer cells.

As indicated by GO analysis, IR- and T-related biological processes were significantly regulated in cat IV and cat IV/1. Amongst others, genes encoding proteins that participate in innate immune responses, like *ccl7/mcp3*, are also represented in these groups. *Ccl7/mcp3*encodes the proinflammatory chemokine C-C motif ligand 7/monocyte chemotactic protein-3. Expression of *ccl7/mcp3*was upregulated by LTβR signaling in each of the genotypes, indicating redundant positive regulation by RelA and RelB or upregulation via another RelA- and RelB-independent pathway.

Collectively, positive regulation of the expression of proinflammatory chemokines like *cx3cl1*, *cxcl10*, *ccl7*(but also others, see Table [12](#T12){ref-type="table"}) by LTβR suggests that LTβR signaling, besides regulating development and organization of secondary lymphoid structures, also participates in innate/inflammatory immune responses and for that primarily RelA action seems to be necessary.

Moreover, we found that LTβR signaling functions beyond the regulation of immune responses and organization of lymphoid structures. PPARγ (peroxisome proliferator activated receptor γ) is a key-regulatory transcription factor in the process of adipocyte differentiation and activation of PPARγ promotes the storage of fat \[[@B35]\]. The work of Fu and colleagues suggests that LTβR affects lipid homeostasis by downregulating hepatic lipase expression \[[@B22]\]. Hepatic lipase is expressed on the surface of hepatocytes in the liver. It promotes receptor-mediated uptake of plasma lipoproteins that harbor triglycerides and cholesterol and specifically catalyzes hydrolysis of triglycerides, actions that are suppressed when LTβR signaling is switched on. Expression of *pparg*was negatively affected by LTβR signaling in wt and *relA*^-/-^but not in *relB*^-/-^cells (belonging to cat II/2 genes), indicating that this gene was downregulated by RelB in response to LTβR stimulation. Our finding is a further indication that LTβR signaling represses lipogenesis and it may do so via RelB. It has been shown that ligand-induced transactivation by PPARγ is suppressed by IL-1 and TNF and that this suppression is mediated through NF-κB (p50-RelA) \[[@B36]\]. However, unlike suppression of PPARγ by p50-RelA, where this heterodimer blocks PPARγ binding to DNA by forming a complex with PPARγ and its co-activator PGC-2, LTβR-mediated suppression of *pparg*occurred via transcriptional repression executed by RelB. Further experiments are required to find out whether RelB directly or indirectly mediates repression of *pparg*transcription in response to LTβR signaling. The repressive effect of LTβR signaling on adipogenesis has been confirmed in MEFs that were induced for adipogenic differentiation. LTβR stimulation resulted in attenuated lipid droplet accumulation as well as in reduced *pparg*and adipogenic marker gene (*fabp4/ap2*) expression under conditions that promote differentiation into adipocytes (unpublished results).

Conclusion
==========

This study is the first systematic dissection of the RelA- and RelB-driven transcriptome response downstream of the LTβR. We confirmed previously described LTβR-regulated genes. More importantly, we identified novel LTβR-responsive genes and assigned underlying regulatory mechanisms executed by RelA and/or RelB to them (Table [13](#T13){ref-type="table"}). We found that the majority of LTβR-regulated genes required the presence of both RelA and RelB, suggesting significant crosstalk between the two NF-κB activation pathways. Gene Ontology analysis confirmed that LTβR-NF-κB target genes were predominantly involved in the regulation of immune responses. However, other biological processes such as apoptosis/cell death, cell cycle, angiogenesis, and taxis were also regulated by LTβR signaling. Furthermore, we show that LTβR stimulation downregulated expression of the gene encoding PPARγ, suggesting that LTβR signaling may repress adipogenic differentiation by attenuating the levels of this key adipogenic transcription factor. Our findings are significant since they indicate a role for LTβR signaling beyond immune responses and lymphoid organ development and assign underlying gene expression regulatory mechanisms to the LTβR transcriptome.

Methods
=======

Cell culture
------------

Mouse embryonic 3T3 fibroblasts (wild-type, *relA*^-/-^, and *relB*^-/-^; kind gift from A. Hoffmann) were cultured at 37°C in Dulbecco\'s modified Eagle\'s medium (GIBCO/Invitrogen, Karlsruhe, Germany) supplemented with 10% heat-inactivated bovine calf serum (Perbio Science, Bonn, Germany), penicillin (100 U/ml), streptomycin (100 μg/ml), and Glutamax I (2 mM) (GIBCO/Invitrogen) and treated with agonistic anti-LTβR mAb (1 μg/ml, clone AC.H6; kind gift from J. Browning and P. Rennert).

EMSA
----

Preparation of nuclear extracts and EMSAs were essentially performed as previously described \[[@B37]\]. Nuclear and cytoplasmic fractions were prepared according to standard procedures \[[@B38]\].

RNA isolation
-------------

Total cellular RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany) according to the manufacturer\'s instructions. Possible contamination by genomic DNA was removed by DNaseI treatment using the RNase-Free DNase Set (Qiagen). Quality of RNA samples was checked by spectrophotometry and agarose gel electrophoresis. RNAs (2 μg total RNA per sample) were used for cRNA preparation for microarrays only when the ratio A260:A280 was 1.8--2.1 and the RNA was intact.

Microarrays
-----------

Microarray analysis was performed using CodeLink UniSet Mouse 20K I bioarrays (GE Healthcare, Munich, Germany), a one-color system where for each of the investigated 19,801 transcripts there is one 30--mer oligo probe spotted per slide. For gene expression profiling, untreated (0 h) and 10 h agonistic anti-LTβR mAb treated wt, *relA*^-/-^, and *relB*^-/-^MEFs were used. For every treatment group, cells from 4 experiments were pooled, total RNA isolated, cRNA prepared and hybridized onto the bioarrays in technical triplicates. cRNA target preparation, bioarray hybridization and detection were carried out according to the manufacturer\'s protocol provided with the CodeLink Expression Assay Reagent Kit. For scanning microarrays, a GenePix 4000B Array Scanner and GenePix Pro 4.0 software (Axon Instruments Inc./Molecular Devices, Munich, Germany) were employed according to settings suggested by the protocol provided with the CodeLink Expression Assay Reagent Kit. Microarray data have been deposited in NCBIs GEO <http://www.ncbi.nlm.nih.gov/geo/> and are accessible through GEO series accession number GSE11963.

Microarray data preprocessing
-----------------------------

Microarray raw data of stimulated and unstimulated MEFs were analyzed using the Codelink™ Expression Analysis v4.1 software (GE Healthcare) and MDFC values were extracted. All subsequent analyses were performed using R and Bioconductor. For the analysis only genes with probe type \'DISCOVERY\' were considered (19,801 genes) and all genes flagged MSR (Manufactory Slide Report) in any sample were excluded (leaving 19,580 genes). To remove negative expression values (local background \> spot intensity) raw intensities with values \< 0.01 were set to 0.01. The raw intensities of each array were scaled to the array median. After logarithmizing the expression values quantile normalization was applied across all arrays.

Differentially expressed genes
------------------------------

Array data for the different genotypes were analyzed separately. A gene was included in the analysis if it was flagged \'G\' (good) or \'S\' (contains saturated pixels) on at least two arrays in any of the two groups (stimulated or unstimulated). Furthermore, genes selected were required to have a FC higher than or equal to the FC threshold determined from the maximum MDFC in these groups. To identify genes significantly differentially expressed after stimulation, a Student\'s *t*-test was performed for the previously filtered genes. The resulting *p*values were corrected for multiple testing using the method of Benjamini and Hochberg \[[@B39]\]. Allowing a false discovery rate of 5%, a total of 528 genes were identified that were significantly regulated in wt cells (regardless whether they were regulated somewhere else). From these, 366 genes were regulated exclusively in wt, 30 genes in wt and *relA*^-/-^, 102 in wt and *relB*^-/-^cells and 30 genes in all 3 genotypes.

Functional analysis with GO
---------------------------

Analysis of functional enrichment was performed employing Fisher\'s exact test. The resulting *p*values (*p*\< 0.01) were used to rank GO terms according to their significance. Terms with more than 600 genes on the array or less than 3 genes on the list of investigated genes were regarded as too general or too specific, respectively, and excluded from the analysis. Expert knowledge was used to assign broader themes to specific GO categories.

qRT-PCR
-------

For qRT-PCR, first strand cDNA was obtained from 2 μg of total RNA for each treatment group using oligo-dT primers and M-MLV Reverse Transcriptase kit (Promega, Mannheim, Germany) according to manufacturer\'s protocols. qRT-PCRs were performed in an iCycler Thermal Cycler real-time PCR machine (Bio-Rad Laboratories, Hercules, CA) using SYBR Green I as detector dye and reagents from the Quantace SensiMix DNA Kit (Quantace Ltd., Watford, UK). Primers for qRT-PCRs with Tm of 60°C were designed using Primer3 software (v. 0.4.0; <http://frodo.wi.mit.edu>) \[[@B40]\]. For individual samples, each gene was tested in triplicates and the mean of the 3 cycle threshold values was used to calculate relative expression levels. For normalization, *β-actin*was used as an endogenous reference gene to correct for variation in RNA content and variation in the efficiency of the reverse transcription reaction. Statistical analysis of qRT-PCR results from 3 independent LTβR stimulation experiments was performed employing a Welch test. Forward (F) and reverse primers (R) in 5\' to 3\' orientation were: Nfkb2_F: GCTAATGTGAATGCCCGGAC, Nfkb2_R: CTTTGGGTATCCCTCTCAGGC, Ccl2_F: CCCACTCACCTGCTGCTACT, Ccl2_R: TCTGGACCCATTCCTTCTTG, IκBα_F: TGCACTTGGCAATCATCCAC, IκBα_R: TTCCTCGAAAGTCTCGGAGCT, Ralgds_F: CATCCACCGCCTAAAGAAGA, Ralgds_R: GGGCTCTCCTAGGGTTCATC, Cx3cl1_F: GGCTAAGCCTCAGAGCATTG, Cx3cl1_R: CATTTTCCTCTGGGGTTGA, Pparg_F: TCATGACCAGGGAGTTCCTC, Pparg_R: GGCGGTCTCCACTGAGAATA, Enpp2_F: TGGCTTACGTGACATTGAGG, Enpp2_R: GTCGGTGAGGAAGGATGAAA, Birc3_F: TGACGTGTGTGACACCAATG, Birc3_R: TGAGGTTGCTGCAGTGTTTC, Cxcl10_F: AAGTGCTGCCGTCATTTTCT, Cxcl10_R: GTGGCAATGATCTCAACACG, Irf1_F: ACCCTGGCTAGAGATGCAGA, Irf1_R: TTTGTATCGGCCTGTGTGAA, Cd74_F: ATGACCCAGGACCATGTGAT, Cd74_R: CCAGGGAGTTCTTGCTCATC, Fosl1_F: CAAAATCCCAGAAGGAGACAAG, Fosl1_R: AAAAGGAGTCAGAGAGGGTGTG, Ccl7_F: AATGCATCCACATGCTGCTA, Ccl7_R: ATAGCCTCCTCGACCCACTT, Cxcl1_F: GCTGGGATTCACCTCAAGAA, Cxcl1_R: TGGGGACACCTTTTAGCATC, Id2_F: CCCCAGAACAAGAAGGTGAC, Id2_R: ATTCAGATGCCTGCAAGGAC, β-actin_F: TGGCGCTTTTGACTCAGGA, β-actin_R: GGGAGGGTGAGGGACTTCC
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